Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duogestan quality of life study in early postmenopausal women
NL-OMON34966Phase 4Withdrawn
- Sponsor
- NVOG
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of estradiol + progesterone and clonidine in menopause (2 arms), sponsored by NVOG. Primary endpoint: Health-related quality of life. Planned start Nov 2009; status: withdrawn.
02
Drugs
estradiol + progesteroneclonidine
03
Conditions
menopause
Beyond the preview
Go deeper on NL-OMON34966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34966.